Enable Accessibility Enable Accessibility

Alliances & Partnerships

At Takeda, we seek partners who believe our global reach, scientific expertise and clinical excellence can help them bring their vision to patients. We seek innovation and partner to nurture it, wherever it resides.

Partnering with Takeda

Takeda’s Center for External Innovation takes an inclusive approach to harnessing innovation from target identification through clinical development and commercialization. Our model supports diverse and flexible approaches to partnership across the discovery and development cycle, including academic alliances, biopharma venture investing and business development partnerships for assets and technologies. 



Active partnerships Takeda has in place globally


Venture investment financings through the Center for External Innovation and Takeda’s strategic venture investing arm, Takeda Ventures, Inc.


New company creations in emerging areas of sciences including gene therapy, gamma delta (γδ) T cell therapy and genome editing


Announcing New Business Development Fellowship Opportunity in the Center for External Innovation

The Center of External Innovation (CEI) team at Takeda is responsible for Business Development (BD) activities which support and enable Takeda’s Research and Development strategy across our core Therapeutic Areas (TA) in Oncology, Neuroscience, Rare Disease and Gastroenterology.  Our team drives external engagement for opportunities ranging from early academic research to late-stage clinical collaborations with the aim to form innovative partnerships which elevate our internal research capabilities and strengthen our pipeline. CEI supports these activities across the BD value chain through cross-functional teams, which include Search & Evaluation (S&E), Project and Diligence Management (PM), Negotiations and Contracting (Transactions), Takeda Academic Innovations (TAI), and Takeda Ventures (TVI) as well as through close alignment with TA leadership. 

The Business Development Fellowship in Innovation at Takeda (BD-FIT) is a 2-year program within CEI that provides early career talent an opportunity to gain specialized, hands-on training and experience in foundational BD activities integral to building an external innovation pipeline within a R&D pharmaceutical environment.

If joining a team whose focus on next-generation innovation is an exciting proposition to you, please review the CEI BD-FIT program brochure and/or the full job description for the Business Development Fellow role. Applications are due by May 31st, 2022 with a target start date for the selected fellow by September 1st, 2022.